prednisolone has been researched along with Colorectal Neoplasms in 6 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Colorectal Neoplasms: Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Treatment was started with 30 mg of prednisolone, and the dosage was gradually decreased." | 1.72 | [A Case of Unilateral Interstitial Lung Disease in a Patient Treated with Oxaliplatin, 5-Fluorouracil, and Leucovorin]. ( Aisaki, K; Aoki, K; Doumoto, Y; Funatsu, K; Hosaka, M; Kimura, T; Kobori, S; Minoshima, K; Ushiku, H; Wakabayashi, M; Yoshida, H, 2022) |
| "Celecoxib is a COX-2 inhibitor drug that can be used to reduce the risk of colorectal adenocarcinoma." | 1.39 | A nitrophenyl-based prodrug type for colorectal targeting of prednisolone, budesonide and celecoxib. ( Gavin, J; Gilmer, JF; Kedziora, K; Kelleher, DP; Keogh, B; Marquez Ruiz, JF; Pigott, M; Windle, H, 2013) |
| "The risk of colorectal cancer was not increased, either in the total group of patients or in patients with colonic Crohn's disease exclusively (standardized morbidity ratio, 1." | 1.32 | Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark. ( Binder, V; Jess, T; Langholz, E; Munkholm, P; Winther, KV, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Kimura, T | 1 |
| Wakabayashi, M | 1 |
| Kobori, S | 1 |
| Aoki, K | 1 |
| Yoshida, H | 1 |
| Minoshima, K | 1 |
| Doumoto, Y | 1 |
| Hosaka, M | 1 |
| Ushiku, H | 1 |
| Aisaki, K | 1 |
| Funatsu, K | 1 |
| Marquez Ruiz, JF | 1 |
| Kedziora, K | 1 |
| Pigott, M | 1 |
| Keogh, B | 1 |
| Windle, H | 1 |
| Gavin, J | 1 |
| Kelleher, DP | 1 |
| Gilmer, JF | 1 |
| Tamura, S | 1 |
| Kusaba, H | 1 |
| Kubo, N | 1 |
| Ijichi, K | 1 |
| Tsuchihashi, K | 1 |
| Komoda, M | 1 |
| Uchino, K | 1 |
| Ariyama, H | 1 |
| Akashi, K | 1 |
| Baba, E | 1 |
| Takeshima, F | 1 |
| Senoo, T | 1 |
| Matsushima, K | 1 |
| Akazawa, Y | 1 |
| Yamaguchi, N | 1 |
| Shiozawa, K | 1 |
| Ohnita, K | 1 |
| Ichikawa, T | 1 |
| Isomoto, H | 1 |
| Nakao, K | 1 |
| Jess, T | 1 |
| Winther, KV | 1 |
| Munkholm, P | 1 |
| Langholz, E | 1 |
| Binder, V | 1 |
| Kibble, A | 1 |
6 other studies available for prednisolone and Colorectal Neoplasms
| Article | Year |
|---|---|
[A Case of Unilateral Interstitial Lung Disease in a Patient Treated with Oxaliplatin, 5-Fluorouracil, and Leucovorin].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Colorectal Neoplasms; Fluorouracil; Humans; Le | 2022 |
A nitrophenyl-based prodrug type for colorectal targeting of prednisolone, budesonide and celecoxib.
Topics: Antineoplastic Agents; Budesonide; Caco-2 Cells; Celecoxib; Cell Membrane Permeability; Clostridium | 2013 |
Interstitial pneumonia during bevacizumab-based chemotherapy for colorectal cancer.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Ch | 2014 |
Successful management of cap polyposis with eradication of Helicobacter pylori relapsing 15 years after remission on steroid therapy.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Amoxicillin; Anti-Bacterial Agents; Anti-Ulcer Agent | 2012 |
Intestinal and extra-intestinal cancer in Crohn's disease: follow-up of a population-based cohort in Copenhagen County, Denmark.
Topics: Adenocarcinoma; Adolescent; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Hor | 2004 |
American Society of Clinical Oncology--43rd annual meeting. Research into therapeutics: Part 3.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Prot | 2007 |